PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1476395
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1476395
According to Stratistics MRC, the Global Recreational Cannabis Market is accounted for $1.93 billion in 2023 and is expected to reach $3.37 billion by 2030 growing at a CAGR of 8.30% during the forecast period. Recreational cannabis refers to the non-medicinal use of cannabis products for enjoyment or relaxation purposes. It's legalized in various regions worldwide, allowing adults to purchase and consume cannabis for recreational purposes. Users typically seek its psychoactive effects, such as euphoria, relaxation, and heightened sensory experiences. Different forms are available, including dried flowers, edibles, concentrates, and tinctures, offering various potency levels and consumption methods.
According to a survey conducted by the Pew Research Center, a US-based think tank, a substantial 88% of U.S. adults expressed a preference for the legalization of marijuana. Specifically, 59% advocate for its legalization for both medical and recreational purposes, while 30% support its legalization solely for medical use.
Legalization and regulation
Legalization and regulation are pivotal drivers of the recreational cannabis market, providing a framework for its cultivation, distribution, and consumption. Legalization removes the stigma and criminality associated with cannabis, fostering a regulated market that ensures product safety and quality. Regulation sets standards for potency, labeling, and packaging, safeguarding consumer health and promoting responsible use. Moreover, it creates opportunities for taxation, generates revenue for governments, and funds public initiatives. This framework also facilitates research into cannabis's medical and therapeutic potential, further expanding its market.
Taxation
Taxation restraint in the recreational cannabis market refers to the imposition of excessive taxes that hinder the growth and viability of the industry. High taxes on cannabis products can lead to inflated prices, driving consumers back to the illegal market. This not only undermines the objectives of legalization, such as regulation and safety, but also limits the tax revenue potential for governments. Moreover, excessive taxation can stifle small businesses and entrepreneurs, creating barriers to entry and favoring larger corporations. Finding a balance in taxation is crucial for fostering a competitive and sustainable recreational cannabis market while ensuring compliance with regulatory standards.
Cannabis cultivation
The recreational cannabis market presents a significant opportunity for cannabis cultivation. With the legalization in many regions, demand has surged, creating a robust market for high-quality cannabis products. Cultivators can capitalize on this by producing strains tailored to consumer preferences, whether it's for relaxation, creativity, or specific medical benefits. Additionally, innovative cultivation techniques, such as hydroponics or organic farming, can differentiate products and attract discerning consumers. Leveraging technology for efficient and sustainable cultivation methods further enhances profitability in this burgeoning market.
Social stigma
The social stigma threat of the recreational cannabis market stems from deeply ingrained societal perceptions and biases surrounding cannabis use. Despite its legalization in many places, negative stereotypes persist, leading to the stigmatization of users. This stigma can manifest in various forms, such as discrimination in employment or housing, social ostracization, and negative labeling. Such attitudes can hinder individuals from seeking help or accessing legitimate cannabis products, perpetuating a cycle of marginalization. Addressing this threat requires widespread education, destigmatization efforts, and policies aimed at promoting understanding and acceptance of cannabis use within society.
The COVID-19 pandemic significantly impacted the recreational cannabis market in several ways. Initially, dispensaries faced closures and restrictions, disrupting supply chains and reducing foot traffic. However, as lockdown measures eased, many regions witnessed a surge in cannabis sales as people sought stress relief and alternative forms of recreation. Additionally, the shift towards online sales and delivery services accelerated, reflecting changing consumer behaviours. Despite these fluctuations, regulatory changes and economic uncertainties affected investments and expansion plans in the industry. Overall, COVID-19 underscored the resilience of the recreational cannabis market while highlighting the need for adaptability and innovation in navigating uncertain times.
The tablets segment is expected to be the largest during the forecast period
The growth of the tablet segment in the recreational cannabis market can be attributed to their convenience and discretion, allowing consumers to easily dose themselves without drawing attention. Additionally, advancements in technology have led to the development of precise dosing and controlled-release formulations, appealing to consumers seeking predictable and consistent effects. Moreover, the trend towards health-conscious consumption has driven demand for alternative methods of cannabis consumption, such as tablets, which offer a smoke-free option. Furthermore, regulatory changes and increasing legalization have expanded the availability of cannabis products, including tablets, driving market growth.
The personal care segment is expected to have the highest CAGR during the forecast period
The growth of the personal care segment can be attributed to an increasing awareness among consumers about the potential therapeutic benefits of cannabis-infused personal care products such as lotions, balms, and bath bombs. These products are being sought after for their reported ability to alleviate pain, reduce inflammation, and provide relaxation. Also, as legalization spreads, there's a burgeoning demand for non-psychoactive cannabis derivatives like CBD, which are often incorporated into personal care items for their purported skin-soothing and anti-inflammatory properties. Additionally, the evolving social acceptance of cannabis has led to a shift in consumer preferences towards natural and organic ingredients, further boosting the appeal of cannabis-infused personal care products.
The growth of the recreational cannabis market in North America has been fueled by a combination of changing attitudes, legalization efforts, and economic potential. With several states in the U.S. and Canada legalizing recreational use, the market has experienced exponential growth. This expansion has led to increased investment, job creation, and tax revenue. Additionally, a shift in consumer preferences towards natural and holistic remedies has driven demand for cannabis products. The evolving regulatory landscape and advancements in cultivation techniques have also contributed to the market's growth trajectory. North America's recreational cannabis market continues to flourish as both entrepreneurs and consumers embrace the opportunities and benefits it offers.
The Asia-Pacific region has seen a notable surge in the recreational cannabis market due to evolving attitudes toward cannabis use and increasing legalization efforts. Countries like Australia, New Zealand, and parts of Southeast Asia are witnessing a growing acceptance of cannabis for leisure purposes, leading to a burgeoning market. Additionally, the region's large population presents a significant consumer base for recreational cannabis products. Moreover, as more nations explore regulatory reforms and decriminalization, investors are increasingly drawn to the potential of this emerging market in the region. This growth is further fueled by the expanding availability of cannabis-related products and the rising demand for alternative wellness solutions.
Key players in the market
Some of the key players in Recreational Cannabis market include 22nd Century Group, Acreage Holdings, Aurora Cannabis Inc., Cannabis Science Inc., Canopy Growth Corporation, Cresco Labs, Front Ventures , HEXO Corp, INDIVA, Medical Marijuana, Inc., Organigrams Holding Inc., Perrigo, PharmaCann Inc., STENOCARE A/S , TerrAscend Corp., The Cronos Group, Tilray Inc., Trulieve, Village Farms International Inc and VIVO Cannabis Inc.
In March 2024, Aurora Cannabis Inc. - The Canadian based leading global medical cannabis company, together with subsidiary company, MedReleaf Australia, have announced the availability of medical cannabis pastilles for doctors to prescribe to patients in Australia. The novel product is produced by Aurora and distributed by MedReleaf Australia, a leading distributor of medical cannabis products with the number two position in the Australian market.
In March 2024, Trulieve Cannabis Corp, a leading and top-performing cannabis company in the U.S., announced the opening of a new medical cannabis dispensary in Cocoa Beach, Florida. The new location will carry a wide variety of popular products including Trulieve's portfolio of in-house brands such as Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One, Sweet Talk, and Trekkers.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.